Water soluble inhibitors of topoisomerase I: Quaternary salt derivatives of camptothecin

被引:34
作者
Lackey, K
Sternbach, DD
Croom, DK
Emerson, DL
Evans, MG
Leitner, PL
Luzzio, MJ
McIntyre, G
Vuong, A
Yates, J
Besterman, JM
机构
[1] GLAXO WELLCOME RES INST,DEPT CELL BIOL,RES TRIANGLE PK,NC 27709
[2] GLAXO WELLCOME RES INST,DEPT PHARMACOL,RES TRIANGLE PK,NC 27709
关键词
D O I
10.1021/jm950507y
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Eleven water soluble 7-substituted quaternary ammonium salt derivatives of 10,11-(methylenedioxy)- and 10,11-(ethylenedioxy)-(20S)-camptothecin were synthesized via the Friedlander reaction followed by nucleophilic displacement with an aromatic amine. All of these compounds were more potent than camptothecin in the in vitro cleavable complex assay. These inherently charged camptothecin derivatives were cytotoxic against three different human tumor cell lines (SKOV3, an ovarian adenocarcinoma; SKVLB a multidrug resistant ovarian adenocarcinoma; and HT-29, a colon carcinoma). A selected group of five compounds was evaluated in the nude mouse HT-29 xenograft model. Two of these quaternary salts (17 and 18) were more efficacious than Topotecan in delaying tumor growth. In an extended in vivo model, 18 demonstrated tumor regression.
引用
收藏
页码:713 / 719
页数:7
相关论文
共 31 条
[1]   PHASE-I AND PHARMACOKINETIC STUDIES OF TOPOTECAN ADMINISTERED AS A 72 OR 120-H CONTINUOUS-INFUSION [J].
BURRIS, HA ;
AWADA, A ;
KUHN, JG ;
ECKARDT, JR ;
COBB, PW ;
RINALDI, DA ;
FIELDS, S ;
SMITH, L ;
VONHOFF, DD .
ANTI-CANCER DRUGS, 1994, 5 (04) :394-402
[2]   REGULATION OF THE FUNCTION OF EUKARYOTIC DNA TOPOISOMERASE-I - ANALYSIS OF THE BINDING STEP AND OF THE CATALYTIC CONSTANTS OF TOPOISOMERIZATION AS A FUNCTION OF DNA TOPOLOGY [J].
CASERTA, M ;
AMADEI, A ;
CAMILLONI, G ;
DIMAURO, E .
BIOCHEMISTRY, 1990, 29 (35) :8152-8157
[3]   TOPOISOMERASE-TARGETING ANTITUMOR DRUGS [J].
DARPA, P ;
LIU, LF .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 989 (02) :163-177
[4]  
EMERSON DL, 1995, CANCER RES, V55, P603
[5]   A KINETIC AND MECHANISTIC STUDY OF THE HYDROLYSIS OF CAMPTOTHECIN AND SOME ANALOGS [J].
FASSBERG, J ;
STELLA, VJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (07) :676-684
[6]   A PHASE-II STUDY OF CPT-11, A NEW DERIVATIVE OF CAMPTOTHECIN, FOR PREVIOUSLY UNTREATED NON-SMALL-CELL LUNG-CANCER [J].
FUKUOKA, M ;
NIITANI, H ;
SUZUKI, A ;
MOTOMIYA, M ;
HASEGAWA, K ;
NISHIWAKI, Y ;
KURIYAMA, T ;
ARIYOSHI, Y ;
NEGORO, S ;
MASUDA, N ;
NAKAJIMA, S ;
TAGUCHI, T ;
ASAKAWA, M ;
NAKABAYASI, T ;
NAKAI, T ;
KURITA, Y ;
KINAMERI, K ;
NOMURA, K ;
NAGAO, K ;
SAIJO, N ;
OHE, Y ;
SUGIURA, T ;
SHIMOKATA, K ;
SAKA, H ;
NEGORO, S ;
NAKAJIMA, S ;
TOHDA, Y ;
FUJII, M ;
OTA, M ;
HARA, N ;
HARA, Y ;
FUJISAWA, K ;
NAKANO, S ;
ARAKI, J ;
NIITANI, H ;
MIYATA, Y .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (01) :16-20
[7]   DNA TOPOISOMERASE-I TARGETED CHEMOTHERAPY OF HUMAN-COLON CANCER IN XENOGRAFTS [J].
GIOVANELLA, BC ;
STEHLIN, JS ;
WALL, ME ;
WANI, MC ;
NICHOLAS, AW ;
LIU, LF ;
SILBER, R ;
POTMESIL, M .
SCIENCE, 1989, 246 (4933) :1046-1048
[8]  
GOTTLIEB JA, 1970, CANCER CHEMOTH REP 1, V54, P461
[9]   MODIFICATION OF THE HYDROXY LACTONE RING OF CAMPTOTHECIN - INHIBITION OF MAMMALIAN TOPOISOMERASE-I AND BIOLOGICAL-ACTIVITY [J].
HERTZBERG, RP ;
CARANFA, MJ ;
HOLDEN, KG ;
JAKAS, DR ;
GALLAGHER, G ;
MATTERN, MR ;
MONG, SM ;
BARTUS, JO ;
JOHNSON, RK ;
KINGSBURY, WD .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (03) :715-720
[10]  
HERTZBERG RP, 1991, DNA TOPOISOMERASES C, P103